CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-04 | MACARTNEY LAWSON Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2015-05-28 | LIGAND PHARMACEUTICALS INC 10% owner | Other acquisition | +228,105 | 4,780,964 | ||
| 2015-05-04 | Lian Brian President & CEO | Returned to the company | −2,313,406 | 1,336,594 | ||
| 2015-05-04 | Lian Brian President & CEO | Grant or award | +87,500 | 1,424,094 | ||
| 2015-05-04 | Lian Brian President & CEO | Conversion | +2,731 | 1,426,825 | ||
| 2015-05-04 | Lian Brian President & CEO | Conversion | +9,927 | 1,436,752 | ||
| 2015-05-04 | Lian Brian President & CEO | Shares withheld for taxes | +16,346 | $9.49 | $155K | 1,453,098 |
| 2015-05-04 | Lian Brian President & CEO | Grant or award · Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2015-05-04 | Lian Brian President & CEO | Conversion · Convertible Note due 2015 | −0 | 0 | ||
| 2015-05-04 | Lian Brian President & CEO | Conversion · Convertible Note due 2015 | −0 | 0 | ||
| 2015-05-04 | Dinerman Michael Chief Operating Officer | Returned to the company | −998,250 | 576,750 | ||
| 2015-05-04 | Dinerman Michael Chief Operating Officer | Grant or award | +105,000 | 681,750 | ||
| 2015-05-04 | Dinerman Michael Chief Operating Officer | Conversion | +3,642 | 685,392 | ||
| 2015-05-04 | Dinerman Michael Chief Operating Officer | Shares withheld for taxes | +8,724 | $9.49 | $83K | 694,116 |
| 2015-05-04 | Dinerman Michael Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2015-05-04 | Dinerman Michael Chief Operating Officer | Conversion · Convertible Note due 2015 | −0 | 3,642 | ||
| 2015-05-04 | MORNEAU MICHAEL Chief Financial Officer | Grant or award | +67,000 | 67,000 | ||
| 2015-05-04 | MORNEAU MICHAEL Chief Financial Officer | Shares withheld for taxes | +10,404 | $9.49 | $99K | 77,404 |
| 2015-05-04 | MORNEAU MICHAEL Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,500 | 25,500 | ||
| 2015-05-04 | Hanley Rochelle Chief Medical Officer | Returned to the company | −158,453 | 91,547 |
Page 26 of 27 · 528 trades